Oesophageal cancer mortality statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Deaths

Deaths from oesophageal cancer, 2015-2017, UK.

Proportion of all deaths

Percentage oesophageal cancer contributes to total cancer deaths, 2015-2017, UK

 

Age

Peak rate of oesophageal cancer deaths, 2015-2017, UK

 

Trend over time

Change in oesophageal cancer mortality rates since the early 1970s, UK

Oesophageal cancer is the 7th most common cause of cancer death in the UK, accounting for 5% of all cancer deaths (2017).[1-3]

In females in the UK, oesophageal cancer is the 7th most common cause of cancer death (3% of all female cancer deaths). In males in the UK it is the 4th most common cause of cancer death (6% of all male cancer deaths).

31% of oesophageal cancer deaths in the UK are in females, and 69% are in males.

Oesophageal cancer mortality rates (European age-standardised (AS) rates) for persons are significantly higher than the UK average in Scotland, and similar to the UK average in all other UK constituent countries.

Oesophageal Cancer (C15), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2017

  England Scotland Wales Northern Ireland UK
Female Deaths 1,946 278 145 47 2,416
Crude Rate 6.9 10.0 9.1 4.9 7.2
AS Rate 6.7 9.5 8.0 5.3 7.0
AS Rate - 95% LCL 6.4 8.4 6.7 3.8 6.7
AS Rate - 95% UCL 7.0 10.7 9.3 6.8 7.3
Male Deaths 4,512 555 291 127 5,485
Crude Rate 16.4 21.0 18.9 13.8 16.8
AS Rate 19.3 23.8 19.7 17.2 19.7
AS Rate - 95% LCL 18.8 21.8 17.5 14.2 19.1
AS Rate - 95% UCL 19.9 25.7 22.0 20.2 20.2
Persons Deaths 6,458 833 436 174 7,901
Crude Rate 11.6 15.4 14.0 9.3 12.0
AS Rate 12.5 15.9 13.4 10.9 12.8
AS Rate - 95% LCL 12.2 14.8 12.2 9.3 12.5
AS Rate - 95% UCL 12.8 17.0 14.7 12.6 13.1

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item 
 
For oesophageal cancer mortality differences between countries largely reflect differences in incidence.

References

  1. Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2017, ICD-10 C15.

Last reviewed:

Oesophageal cancer mortality is strongly related to age, with the highest mortality rates being in older people. In the UK in 2015-2017, on average each year almost half (47%) of deaths were in people aged 75 and over.[1-3] This largely reflects higher incidence and lower survival for oesophageal cancer in older people.

Age-specific mortality rates rise steeply from around age 45-49. The highest rates are in the 85 to 89 age group for females and the 90+ age group for males. Mortality rates are significantly lower in females than males in a number of (mainly older) age groups. The gap is widest at age 35 to 39,when the age-specific mortality rate is 5.2 times lower in females than in males.

Oesophageal Cancer (C15), Average Number of Deaths per Year and Age-Specific Mortality Rates per 100,000 Population, UK, 2015-2017

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

References

  1. Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2015-2017, ICD-10 C15.

Last reviewed:

Oesophageal cancer European age-standardised (AS) Open a glossary item mortality rates for females and males combined increased by 43% in the UK between 1971-1973 and 2015-2017.[1-3] The increase was larger in males than in females.

For females, oesophageal cancer AS mortality rates in the UK increased by 5% between 1971-1973 and 2015-2017. For males, oesophageal cancer AS mortality rates in the UK increased by 57% between 1971-1973 and 2015-2017.

Over the last decade in the UK (between 2005-2007 and 2015-2017), oesophageal cancer AS mortality rates for females and males combined decreased by 9%.[1-3] In females AS mortality rates decreased by 15%, and in males rates decreased by 7%.

Oesophageal Cancer (C15), European Age-Standardised Mortality Rates per 100,000 Population, UK, 1971-2017

For most cancer types, mortality trends largely reflect incidence and survival trends. For example, rising mortality may reflect rising incidence and stable survival, while falling mortality may reflect rising incidence and rising survival.

Oesophageal cancer mortality rates have varied between age groups in females in the UK since the early 1970s.[1-3] Rates in 25-49s have decreased by 47%, in 50-59s have decreased by 22%, in 60-69s have remained stable, in 70-79s have remained stable, and in 80+s have increased by 18%.

Oesophageal Cancer (C15), European Age-Standardised Mortality Rates per 100,000 Population, By Age, Females, UK, 1971-2017

Oesophageal cancer mortality rates have increased overall in all broad adult age groups in males in the UK since the early 1970s.[1-3] Rates in 25-49s have increased by 24%, in 50-59s have increased by 45%, in 60-69s have increased by 63%, in 70-79s have increased by 57%, and in 80+s have increased by 61%.

Oesophageal Cancer (C15), European Age-Standardised Mortality Rates per 100,000 Population, By Age, Males, UK, 1971-2017

References

  1. Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1971-2017, C15.

Last reviewed:

Oesophageal cancer mortality rates are projected to fall by 16% in the UK between 2014 and 2035, to 13 deaths per 100,000 people by 2035.[1] This includes a larger decrease for males than for females.

For males, oesophageal cancer European age-standardised (AS) Open a glossary item mortality rates in the UK are projected to fall by 18% between 2014 and 2035, to 19 deaths per 100,000 by 2035.[1] For females, rates are projected to fall by 17% between 2014 and 2035, to 8 deaths per 100,000 by 2035.[1]

Oesophageal cancer (C15), Observed and Projected Age-Standardised Mortality Rates, by Sex, UK, 1979-2035

 

It is projected that 9,748 deaths from oesophageal cancer (6,571 in males, 3,177 in females) will occur in the UK in 2035.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C15

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

There is evidence for an association between oesophageal cancer mortality and deprivation for both males and females in England.[1] England-wide data for 2007-2011 show European age-standardised Open a glossary item mortality rates are 60% higher for males living in the most deprived areas compared with the least deprived, and 50% higher for females.[1]

Oesophageal Cancer (C15), European Age-Standardised Mortality Rates by Deprivation Quintile, England, 2007-2011

The estimated deprivation gradient in oesophageal cancer mortality between people living in the most and least deprived areas in England has not changed in the period 2002-2011.[1] It has been estimated that there would have been around 1,100 fewer cancer deaths each year in England during 2007-2011 if all people experienced the same mortality rates as the least deprived.[1]

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for: UK, 2007-2011, ICD-10 C15

Deprivation gradient statistics were calculated using mortality data for 2007-2011. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.